Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
18.20
-0.56 (-2.99%)
Dec 5, 2025, 4:00 PM EST - Market closed
Bicara Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -121.52 | -68 | -51.99 | -37.85 |
| Depreciation & Amortization | 0.08 | 0.06 | 0.02 | 0.01 |
| Asset Writedown & Restructuring Costs | - | - | 0.57 | - |
| Stock-Based Compensation | 13.74 | 7.4 | 1.9 | 0.81 |
| Other Operating Activities | 0.32 | -0.08 | 13.5 | - |
| Change in Accounts Payable | 6.85 | 2.64 | -8.66 | 5.87 |
| Change in Other Net Operating Assets | -12.48 | -16.77 | -0.96 | -0.92 |
| Operating Cash Flow | -112.98 | -74.75 | -45.63 | -32.08 |
| Capital Expenditures | -0.08 | -0.07 | -0.59 | -0.19 |
| Sale of Property, Plant & Equipment | - | 0.06 | - | - |
| Investing Cash Flow | -236.16 | -0.01 | -0.59 | -0.19 |
| Issuance of Common Stock | 0.06 | 334.03 | 0.15 | 0.16 |
| Financing Cash Flow | 0.06 | 334.03 | 272.5 | 31.7 |
| Net Cash Flow | -349.09 | 259.27 | 226.28 | -0.57 |
| Free Cash Flow | -113.06 | -74.82 | -46.21 | -32.27 |
| Free Cash Flow Per Share | -2.07 | -4.45 | -79.66 | -75.20 |
| Cash Income Tax Paid | 0.29 | - | - | 0 |
| Levered Free Cash Flow | -75.16 | -53.72 | -32.5 | - |
| Unlevered Free Cash Flow | -75.16 | -53.72 | -32.5 | - |
| Change in Working Capital | -5.63 | -14.13 | -9.62 | 4.95 |
Source: S&P Capital IQ. Standard template.
Financial Sources.